2026 AGENDA

Boston, 29 - 30 September 2026

Schedule

• Sep 29
• Sep 30

Filter your schedule:

Topics:

Keynote Session FAIR Data: Management, Storage and Architecture AI in Clinical Trials Real World Evidence Large Language Models Digital Transformation AI in Drug Discovery and Development Startup Pitches Bioinformatics + InSilico R&D

Start time filter:

Morning (8-11.30) Midday (11.30-2.30) Afternoon (2.30-6.30)

Favourites:

Favourites only

Retrieve Save

Clear filters

Create your personal agenda –check the favourite icon

Sep 298:50

Conference pass

Introductory remarks

Keynotes

Anna Abiola, Conference Director, Terrapinn Holdings Ltd

Sep 298:55

Conference pass

Chair's remarks

Keynotes

Emily Gillen, Head of Global Data Partnerships, UCB

Sep 299:00

Conference pass

Keynote presentation

Keynotes

Peter Marks, SVP Molecule Discovery and Head of Infectious Diseases, Eli Lilly

Sep 299:20

Conference pass

Investment trends in AI

Keynotes

Moderator: Rana Lonnen, General Partner, Science Capital Ventures

Issa Kildani, Managing Partner, Founder, Ambrosia Ventures

Pooja Majmudar, Investment Partner, KELES Digital Health

Divya Yerraguntla, Angel Investor, Life Science Angels

Sarah Johnson, Partner, Advantary Capital Partners

Sep 2911:40

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Sree Chitoor, Chief Technology Officer, IAVI

Sep 2911:40

Conference pass

Chair's remarks

AI in Clinical Trials

J.P. Li, Co-Chairman / Angel Investor, Meridian Universal Health Group Inc. / Wharton Alumni Angels

Sep 2911:40

Conference pass

Chair's remarks

Real World Evidence

Catherine Brownstein, Assistant Professor, Harvard Medical School

Sep 2911:40

Conference pass

Chair's remarks

Large Language Models

Dr. Nick (Nemanja) Kovacev, Surgeon/Engineer, OrtoMD Polyclinic

Sep 2911:40

Conference pass

Chair's remarks

Digital Transformation

Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc

Sep 2911:40

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Christopher Bishop, Chief Reinvention Officer, Improvising Careers

Sep 2911:45

Conference pass

AI-Driven Endpoints: Redefining Clinical Trials for the Next Decade

AI in Clinical Trials

Agata Krason, Medical Imaging Data Scientist, Roche

Sep 2911:45

Conference pass

AI-ready data, foundation models, and agents for clinical trial optimization

AI in Drug Discovery and Development

Etai Jacob, Head of Data Science and AI, Oncology R&D, AstraZeneca

Sep 2911:45

Conference pass

Data transformation is not a line it’s a circle

Digital Transformation

Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc

Sep 2911:45

Conference pass

Engineering Certainty and Clinical Safety: From Probabilistic to Deterministic AI

Large Language Models

Dr. Nick (Nemanja) Kovacev, Surgeon/Engineer, OrtoMD Polyclinic

Sep 2911:45

Conference pass

Integration of real world evidence in genomics discovery

Real World Evidence

Catherine Brownstein, Assistant Professor, Harvard Medical School

Sep 2911:45

Conference pass

Safety Data Management & AI Automation

FAIR Data: Management, Storage and Architecture

Vikalp Khare, Director, US Head of Safety Data Management, Otsuka Pharmaceutical

Sep 2912:05

Conference pass

Generative AI for the Lab: Streamlining Scientific Workflows Through Intelligent Integration

AI in Clinical Trials

Akhil Rachamadugu, Director, Life Sciences, ServiceNow

Sep 2912:05

Conference pass

In Silico-Enabled Biologics: Transforming Molecular Biology Design Through Integrated Informatics

Digital Transformation

Veronica DeFelice, Director of Biologics, Sapio Sciences

Sep 2912:25

Conference pass

Accelerating trial selection with AI agents

Real World Evidence

Irfan Shah, Digital Ventures, Memorial Sloan Kettering Cancer Center

Sep 2912:25

Conference pass

AI-driven trial design and optimization

AI in Clinical Trials

J.P. Li, Co-Chairman / Angel Investor, Meridian Universal Health Group Inc. / Wharton Alumni Angels

Sep 2912:25

Conference pass

AI-powered programmable virtual humans for physiologically based drug discovery

AI in Drug Discovery and Development

Lei Xie, Professor, Northeastern University

Sep 2912:25

Conference pass

Implementation of new age AI solutions and how to keep up with them

Digital Transformation

Anubhav Srivastava, Associate Director, Novo Nordisk Inc.

Sep 2912:25

Conference pass

Multimodal Multi-Agent Solution for Sales Representatives

Large Language Models

Shihan He, Machine Learning Engineer, Novo Nordisk Inc.

Sep 2912:25

Conference pass

The Data Dilemma: Storage, Management, and the Privacy Puzzle

FAIR Data: Management, Storage and Architecture

Joel Schwarz, Adjunct Law Professor, Cybersecurity and Privacy, Albany Law School

Sep 2913:05

Conference pass

A data science ecosystem for pharma R&D

FAIR Data: Management, Storage and Architecture

Daniel Gusenleitner, Mission Lead of the Pharma R&R Data Science Ecosystem, Bayer

Sep 2913:05

Conference pass

A data science ecosystem for pharma R&D

FAIR Data: Management, Storage and Architecture

Daniel Gusenleitner, Mission Lead of the Pharma R&R Data Science Ecosystem, Bayer

Sep 2913:05

Conference pass

Digital transformation in biotherapeutics discovery

Digital Transformation

Alexander Horspool, Associate Director of Data and Lab Automation, Boehringer Ingelheim

Sep 2913:05

Conference pass

DNA Methylation-Mediated Epigenetic Adaptation Promotes Cellular Resilience In AML

Real World Evidence

Manna Ahmed, Assistant Research Professor - Manager of The Genomics Resource Facility, Fox Chase Cancer Center

Sep 2913:05

Conference pass

Navigating launch challenges in rare disease markets

AI in Drug Discovery and Development

Soumavo Sarkar, Director, Novartis

Sep 2913:05

Conference pass

Physics-Informed Large Language Models for Biologics: Applying Nuclear Engineering Rigor to AI Safety and Reliability

Large Language Models

Daya Shankar, Founder & Chief AI Officer, VaidyaAI, Dean School of Sciences & AI Faculty, Woxsen University, Woxsen University

Sep 2913:05

Conference pass

Virtual patient generation leveraging RWD to expedite clinical development

AI in Clinical Trials

Yilin Xu, Head of clinical data analytics, AbbVie

Sep 2913:25

Conference pass

The Agent Did It. Now Can You Prove It? Cryptographic Traceability for AI in Clinical Workflows

Startup Pitches

Alistair Dootson, Head Life Sciences, EQTY Life Sciences

Tina Morrison, Head of Life Sciences, EQTY Lab

Sep 2913:40

Conference pass

Responsible AI by Design: How to Launch Agentic AI in Regulated Biotech

Startup Pitches

Atika Kumar, Founder, Wiztree Consulting

Sep 2913:55

Conference pass

AI-Driven Insights from Every single Patient

Startup Pitches

Mattia Marco Caruson, Founder and CEO, mama health technologies

Sep 2914:25

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Christopher Bishop, Chief Reinvention Officer, Improvising Careers

Sep 2914:25

Conference pass

Chair's remarks

Large Language Models

Saeed Amal, Research Professor In AI for Precision Medicine at Northeastern University and Visiting Professor at Harvard Medical School, Northeastern University

Sep 2914:25

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Lori Hoepner, Asst Professor, SUNY DOWNSTATE

Sep 2914:25

Conference pass

Chair's remarks

AI in Clinical Trials

Soumavo Sarkar, Director, Novartis

Sep 2914:25

Conference pass

Chair's remarks

AI in Clinical Trials

Soumavo Sarkar, Director, Novartis

Sep 2914:25

Conference pass

Chair's remarks

Real World Evidence

Michael Liebman, Managing Director, IPQ Analytics. LLC

Sep 2914:30

Conference pass

AI based first draft document authoring in support of clinical trials

AI in Drug Discovery and Development

Chris Willis, Director, Research Business Insights & Technology, Bristol Myers Squibb

Sep 2914:30

Conference pass

Development Assistant: Empowering AZ with Interoperable, Context‑Driven Insights

AI in Clinical Trials

Betsy luo, IT Business Analyst, AstraZeneca

Sep 2914:30

Conference pass

Digital Transformation in Biomedical Research: Challenges and Opportunities

Digital Transformation

Jason Beckwith, Professor, University of Dundee

Sep 2914:30

Conference pass

Large Language Models in Practice: From Patient Support to Precision Cancer Care

Large Language Models

Omer Alis, Director of Artificial Intelligence, Northeastern University

Sep 2914:30

Conference pass

Multi-cancer Early Detection (MCED)

Real World Evidence

Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center

Sep 2914:30

Conference pass

Pitfalls and Best Practices: Notes from the (research) field

FAIR Data: Management, Storage and Architecture

Lori Hoepner, Asst Professor, SUNY DOWNSTATE

Sep 2915:10

Conference pass

Agentic AI for biotech competitive intelligence

Large Language Models

Daniel de Moraes Branco, Senior Director Corporate Development, Latin America Medical Affairs Lead, Artiva Biotherapeutics

Sep 2915:10

Conference pass

AI in Drug Development and Discovery - an investors perspective

AI in Drug Discovery and Development

Colby Kash, Ceo, Camelot BioCapital

Sep 2915:10

Conference pass

Digital innovations driving clinic trials efficiencies

AI in Clinical Trials

Naomi Fried, CEO, Pharmstars

Sep 2915:10

Conference pass

From Data Custodian to Data Product Leader: Building FAIR and AI-Ready Clinical Data Platforms for Precision Trials

FAIR Data: Management, Storage and Architecture

Kayure Patel, Senior Data Sciences Product Leader, Genentech/Roche

Sep 2915:10

Conference pass

HEART: Healthcare Enabled by AI in Real Time

Real World Evidence

Qingchu Jin, Research Scientist, Northeastern University

Sep 2915:10

Conference pass

Securing the Agentic Future: How Privacy and Trust Drive Real Digital Transformation

Digital Transformation

Preetha Ram, Managing Partner, Pier 70 Ventures

Sep 2915:30

Conference pass

The Skills Behind the Strategy: Preparing Today's Workforce for Digital Transformation

Digital Transformation

Uwe Hohgrawe, Associate Dean Global Learner Access, Strategic Partnerships and AI, Northeastern University

Sep 2915:50

Conference pass

AI ML for drug discovery

AI in Drug Discovery and Development

Srijit Seal, Visiting Researcher, Broad Institute of MIT and Harvard

Sep 2915:50

Conference pass

Applications of biological foundation models to accelerate clinical trials

AI in Clinical Trials

Neil Pfister, Assistant Professor; Head of AI in Precision Medicine Research Group, University of Alabama at Birmingham

Sep 2915:50

Conference pass

Digital transformation within medical and scientific communications within pharma and biotech

Digital Transformation

Michelle Bridenbaker, Head of Medical Excellence & Communications, Recordati

Sep 2915:50

Conference pass

Diving deeper into indications

FAIR Data: Management, Storage and Architecture

Maureen Stark, Biospecimen Senior Specialist - Data Mgt, Roche

Sep 2916:40

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Pooja Majmudar, Investment Partner, KELES Digital Health

Sep 2916:40

Conference pass

Chair's remarks

Digital Transformation

Shabana Motlani, Director, USO PS QA & GxP Automation & Analytics, Novo Nordisk

Sep 2916:40

Conference pass

Chair's remarks

AI in Clinical Trials

Jin Lee, Founder, IMIDeology

Sep 2916:40

Conference pass

Chair's remarks

Real World Evidence

Michael Liebman, Managing Director, IPQ Analytics. LLC

Sep 2916:45

Conference pass

Bridging the gap between FEMtech and FEMhealth

Real World Evidence

Michael Liebman, Managing Director, IPQ Analytics. LLC

Sep 2916:45

Conference pass

Leveraging Data and AI to transform Research, Care, and Operations at Sylvester Comprehensive Cancer Center

Digital Transformation

Vasileios Stathias, Assistant Director, Data Science, Sylvester Comprehensive Cancer Center

Sep 2916:45

Conference pass

Protecting Our Cognitive Edge: The Paradox of AI Offloading vs. Skills Atrophy

AI in Clinical Trials

Lincoln Shand, Global Technical Leader, Data Management, PD Data Science and Analytics, Roche

Sep 2916:45

Conference pass

ROI on AI implantation in drug discovery

AI in Drug Discovery and Development

Pooja Majmudar, Investment Partner, KELES Digital Health

Sep 2917:05

Conference pass

How Novo Nordisk Transformed Customer targeting using AI

Digital Transformation

Sai Rithvik Kanakamedala, Data Scientist, Novo Nordisk

Sep 2917:25

Conference pass

AI-Powered Trials: Unlocking Leadership in Clinical Innovation

AI in Clinical Trials

Moderator: Angela Gill Nelms, Managing Director, Biolocity at GT and Emory

Yilin Xu, Head of clinical data analytics, AbbVie

Hong Truong, Principal, Define Ventures

Sep 2917:25

Conference pass

Better ways to recruit and retain patients

Real World Evidence

Moderator: Jin Lee, Founder, IMIDeology

Sep 2917:25

Conference pass

Digital health and AI, what does the future hold?

Digital Transformation

Moderator: Naomi Fried, CEO, Pharmstars

Omer Alis, Director of Artificial Intelligence, Northeastern University

Sep 2917:25

Conference pass

The Health Data Trilemma: Privacy, National Security, and Borderless dataflows

FAIR Data: Management, Storage and Architecture

Moderator: Joel Schwarz, Adjunct Law Professor, Cybersecurity and Privacy, Albany Law School

Sep 2917:25

Conference pass

Using AI in the drug development and discovery process

AI in Drug Discovery and Development

Moderator: Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs, University of Washington

Create your personal agenda –check the favourite icon

Sep 308:50

Conference pass

Introductory remarks

Keynotes

Anna Abiola, Conference Director, Terrapinn Holdings Ltd

Sep 309:40

Conference pass

Evolution of women’s health

Keynotes

Moderator: Michelle Bridenbaker, Head of Medical Excellence & Communications, Recordati

Preetha Ram, Managing Partner, Pier 70 Ventures

Sep 3011:40

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Venkat Sanka, Data Analytics & Governance Consultant, Janssen Global Services LLC

Sep 3011:40

Conference pass

Chair's remarks

AI in Drug Discovery and Development

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence, Merck

Sep 3011:40

Conference pass

Chair's remarks

Bioinformatics + InSilico R&D

Qingchu Jin, Research Scientist, Northeastern University

Sep 3011:40

Conference pass

Chair's remarks

AI in Clinical Trials

Angela Gill Nelms, Managing Director, Biolocity at GT and Emory

Sep 3011:45

Conference pass

AI in medical authoring and regulatory intelligence

AI in Clinical Trials

Sree Chitoor, Chief Technology Officer, IAVI

Sep 3011:45

Conference pass

From High-Throughput Pipelines to FAIR Data: A Storage Strategy

FAIR Data: Management, Storage and Architecture

Venkat Sanka, Data Analytics & Governance Consultant, Janssen Global Services LLC

Sep 3011:45

Conference pass

Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D

Real World Evidence

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence, Merck

Sep 3011:45

Conference pass

How AI can help early stage companies in drug development

AI in Drug Discovery and Development

Lou Kassa, CEO, Pennsylvania Biotechnology Center

Sep 3011:45

Conference pass

When Quantum Meets Pharma: Inside the Race to Design Drugs Atom by Atom

Bioinformatics + InSilico R&D

Christopher Bishop, Chief Reinvention Officer, Improvising Careers

Sep 3012:25

Conference pass

Building Bridges: Developing a Common Omics Data Platform at AbbVie

FAIR Data: Management, Storage and Architecture

Brett Engelmann, Sr Data Scientist, AbbVie

Sep 3012:25

Conference pass

Multi-modal real world data foundation models: Challenges & opportunities

AI in Drug Discovery and Development

Janie Shelton, Director, Translational Epidemiology, Bristol Myers Squibb

Sep 3012:25

Conference pass

Patient advocate journey through trials

AI in Clinical Trials

Ella Balasa, Patient Engagement Consultant, Patient Advocate

Sep 3012:25

Conference pass

The Convergence of Patient Safety and Real-World Evidence in a Data-Driven Era

Real World Evidence

Osamagbe Woghiren, Senior Manager, QPPV Office & PV Operations (Global Pharmacovigilance), UCB

Sep 3012:25

Conference pass

Virtual cell modelling

Bioinformatics + InSilico R&D

Jake Chen, Endowed Professor and Director, University of Alabama at Birmingham

Sep 3013:05

Conference pass

From Silos to FAIR: Driving Data Strategy in Research and Development

FAIR Data: Management, Storage and Architecture

Harish Manmathan, Sr. Director, Trial Delivery Data Strategy, Takeda

Sep 3013:05

Conference pass

How to integrate multi-omics

Bioinformatics + InSilico R&D

Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard

Sep 3013:05

Conference pass

Leveraging RWD in the Drug Development Process

Real World Evidence

Thomas Dougherty, Data Science & AI Innovative Partnership Lead, Novo Nordisk

Sep 3013:05

Conference pass

Mind the Gap: How Artificial Intelligence Can Strengthen the Clinical Trial Enterprise from Protocol Design to External Controls

AI in Clinical Trials

Alexander Sherman, Director, Center for Innovation and Bioinformatics, Mass General Hospital, Harvard Medical School

Sep 3013:05

Conference pass

Revolutionizing immunotherapy through patient-centric therapeutic hardware platform, ATT-AI

AI in Drug Discovery and Development

David Sherris, CEO, Attivare Therapeutics

Sep 3014:25

Conference pass

Chair's remarks

FAIR Data: Management, Storage and Architecture

Venkat Sanka, Data Analytics & Governance Consultant, Janssen Global Services LLC

Sep 3014:25

Conference pass

Chair's remarks

AI in Clinical Trials

Angela Gill Nelms, Managing Director, Biolocity at GT and Emory

Sep 3014:30

Conference pass

AI influenced nano technology in drug discovery and development

AI in Drug Discovery and Development

Beauty Pandey, Associate Dean & Associate Professor, Woxsen University

Sep 3014:30

Conference pass

Detecting Dengue, Chikungunya, and Oropouche Viruses Using Radio Frequency Waves and Machine Learning.

Bioinformatics + InSilico R&D

Omer Alis, Director of Artificial Intelligence, Northeastern University

Sep 3014:30

Conference pass

Driving field medical innovation

Real World Evidence

Karuna Kantor, Director, Field Medical, Novo Nordisk

Sep 3014:50

Conference pass

How AI is used to support the three R’s in drug discovery

AI in Drug Discovery and Development

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs, University of Washington

Sep 3015:10

Conference pass

An ensemble method for robust labelling of single-cell RNA-seq data

Bioinformatics + InSilico R&D

MaryLena Bleile, Senior Statistician, Sanofi

Sep 3015:10

Conference pass

Regulatory affairs, The regulations and guidance globally

AI in Drug Discovery and Development

Jia Huang, Associate Director, Merck

Sep 3015:50

Conference pass

Pediatric Precision Medicine

Keynotes

Wendy Chung, Chief, Department of Pediatrics, Boston Children's Hospital

last published: 31/Mar/26 17:15 GMT

×

Your personalised agenda

You can save your preferred agenda items for future reference. If you reset your password an new one will be sent to the email address specified below, that we have on account.

Your email address…

Your password…

CloseLoginReset password

Password must meet the following requirements:

• At least one letter
• At least one capital letter
• At least one number
• Be at least 6 characters

×

Divya Yerraguntla / Investment trends in AI

Divya Yerraguntla, Angel Investor,
Life Science Angels

An established leader and influencer in the Pharmaceutical industry, Divya has been in the industry for more than 25 years, working with companies such as Johnson & Johnson, Novo Nordisk, SUN Pharma, and Syneos Health. She is a seasoned Speaker and chairperson of various Pharmaceutical Forums...

CloseMore

×

J.P. Li / Chair's remarks

J.P. Li, Co-Chairman / Angel Investor,
Meridian Universal Health Group Inc. / Wharton Alumni Angels

Mengyue (J.P.) Li – Biography With domestic and international experience across higher education, banking, healthcare, and venture capital (VC) & private equity (PE), J.P. embarked on his first entrepreneurial journey by acquiring and scaling a local business in Houston, Texas. Under his...

CloseMore

×

Jennifer Heymont / Chair's remarks

Jennifer Heymont, Associate Director, Scientific Informatics,
Eisai Inc

Jennifer's strong foundation in math and biology naturally led to a career in data science. Beginning as a Scientific Applications Developer over 15 years ago, today she is the Associate Director of Scientific Informatics at Eisai G2D2. In this role, she focuses on processes that transform data ...

CloseMore

×

Christopher Bishop / Chair's remarks

Christopher Bishop, Chief Reinvention Officer,
Improvising Careers

Christopher Bishop is a TEDx speaker, ex-IBMer, former NYC studio cat, touring rock musician, future workplace consultant, and a firm believer in the power of bleeding-edge technologies to drive exciting and innovative careers. He is the author of the groundbreaking new book Improvising Careers:...

CloseMore

×

Agata Krason / AI-Driven Endpoints: Redefining Clinical Trials for the Next Decade

Agata Krason, Medical Imaging Data Scientist,
Roche

Agata Krason is a Clinical AI Scientist and Senior Medical Imaging Data Scientist at F. Hoffmann-La Roche Ltd, where she works at the intersection of artificial intelligence, medical imaging, and clinical data science to accelerate precision oncology. Her research focuses on building clinically...

CloseMore

×

Jennifer Heymont / Data transformation is not a line it’s a circle

Jennifer Heymont, Associate Director, Scientific Informatics,
Eisai Inc

Jennifer's strong foundation in math and biology naturally led to a career in data science. Beginning as a Scientific Applications Developer over 15 years ago, today she is the Associate Director of Scientific Informatics at Eisai G2D2. In this role, she focuses on processes that transform data ...

CloseMore

×

J.P. Li / AI-driven trial design and optimization

J.P. Li, Co-Chairman / Angel Investor,
Meridian Universal Health Group Inc. / Wharton Alumni Angels

Mengyue (J.P.) Li – Biography With domestic and international experience across higher education, banking, healthcare, and venture capital (VC) & private equity (PE), J.P. embarked on his first entrepreneurial journey by acquiring and scaling a local business in Houston, Texas. Under his...

CloseMore

×

Anubhav Srivastava / Implementation of new age AI solutions and how to keep up with them

Anubhav Srivastava, Associate Director,
Novo Nordisk Inc.

Anubhav Srivastava is an accomplished professional with over 19 years of experience in the pharmaceutical and healthcare industry. Currently serving as the Associate Director at Novo Nordisk Inc., Anubhav is a visionary leader known for driving innovation and precision in the field. With a strong...

CloseMore

×

Christopher Bishop / Chair's remarks

Christopher Bishop, Chief Reinvention Officer,
Improvising Careers

Christopher Bishop is a TEDx speaker, ex-IBMer, former NYC studio cat, touring rock musician, future workplace consultant, and a firm believer in the power of bleeding-edge technologies to drive exciting and innovative careers. He is the author of the groundbreaking new book Improvising Careers:...

CloseMore

×

Saeed Amal / Chair's remarks

Saeed Amal, Research Professor In AI for Precision Medicine at Northeastern University and Visiting Professor at Harvard Medical School,
Northeastern University

Prof. Saeed Amal is a Research Professor in Bioengineering at Northeastern University and affiliated with the Roux Institute. He isa visiting professor at Harvard Medical School. Prof. Amal won the National Academy of Inventors Award of " Emerging Visionary Award in AI for...

CloseMore

×

Michelle Bridenbaker / Digital transformation within medical and scientific communications within pharma and biotech

Michelle Bridenbaker, Head of Medical Excellence & Communications,
Recordati

Michelle Bridenbaker is currently the Global Head of Medical Excellence & Communications at Recordati. Additionally, in her capacity as the Vice President Elect of Medical Information Leaders in Europe (MILE) a pan-pharmaceutical company coalition, she helps shape industry best...

CloseMore

×

Jin Lee / Chair's remarks

Jin Lee, Founder,
IMIDeology

Dr. Jin Lee is the Co-Founder and CEO of IMIDeology, a clinician-led autoimmune research network that bridges patients with practicing specialists in rheumatology, dermatology, and gastroenterology. She has worked across the healthcare ecosystem—from pharma and health insurance to hospital system...

CloseMore

×

Angela Gill Nelms / AI-Powered Trials: Unlocking Leadership in Clinical Innovation

Angela Gill Nelms, Managing Director,
Biolocity at GT and Emory

I’m a founder, board leader, podcaster, and award-winning entrepreneur with a career spanning SaaS, medical devices, and clinical research. I build high-impact teams and organizations rooted in culture, resilience, and strategic execution—globally and sustainably. I host three shows that each...

CloseMore

×

Jin Lee / Better ways to recruit and retain patients

Jin Lee, Founder,
IMIDeology

Dr. Jin Lee is the Co-Founder and CEO of IMIDeology, a clinician-led autoimmune research network that bridges patients with practicing specialists in rheumatology, dermatology, and gastroenterology. She has worked across the healthcare ecosystem—from pharma and health insurance to hospital system...

CloseMore

×

Sally Thompson-Iritani / Using AI in the drug development and discovery process

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs,
University of Washington

Sally Thompson-Iritani is an accomplished professional with a passion for advancing animal care, outreach, and the principles of the 3Rs (Replacement, Reduction, Refinement) in research. As the Assistant Vice Provost at the University of Washington, she leads initiatives to promote ethical and...

CloseMore

×

Michelle Bridenbaker / Evolution of women’s health

Michelle Bridenbaker, Head of Medical Excellence & Communications,
Recordati

Michelle Bridenbaker is currently the Global Head of Medical Excellence & Communications at Recordati. Additionally, in her capacity as the Vice President Elect of Medical Information Leaders in Europe (MILE) a pan-pharmaceutical company coalition, she helps shape industry best...

CloseMore

×

Venkat Sanka / Chair's remarks

Venkat Sanka, Data Analytics & Governance Consultant,
Janssen Global Services LLC

Venkat Sanka is a seasoned data and cloud analytics leader with over 16 years of experience enabling data-driven transformation across healthcare, life sciences, and global enterprises. He currently works in data analytics and governance, leading initiatives in AI/ML, cloud platforms, and trusted...

CloseMore

×

Anu Sharma / Chair's remarks

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence,
Merck

Anu Sharma is a Senior Principal Scientist and Real World Evidence platforms leader at Merck. She leads Data Sciences, Platform Strategy and Health Economic Modeling Initiatives within the MRL Biostatistics and Research Decision Sciences(BARDS) Epidemiology RWE Capabilities and Analytics working...

CloseMore

×

Angela Gill Nelms / Chair's remarks

Angela Gill Nelms, Managing Director,
Biolocity at GT and Emory

I’m a founder, board leader, podcaster, and award-winning entrepreneur with a career spanning SaaS, medical devices, and clinical research. I build high-impact teams and organizations rooted in culture, resilience, and strategic execution—globally and sustainably. I host three shows that each...

CloseMore

×

Venkat Sanka / From High-Throughput Pipelines to FAIR Data: A Storage Strategy

Venkat Sanka, Data Analytics & Governance Consultant,
Janssen Global Services LLC

Venkat Sanka is a seasoned data and cloud analytics leader with over 16 years of experience enabling data-driven transformation across healthcare, life sciences, and global enterprises. He currently works in data analytics and governance, leading initiatives in AI/ML, cloud platforms, and trusted...

CloseMore

×

Anu Sharma / Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D

Anu Sharma, Senior Principal Scientist, Sr. Director, Outcomes Research Real World Evidence,
Merck

Anu Sharma is a Senior Principal Scientist and Real World Evidence platforms leader at Merck. She leads Data Sciences, Platform Strategy and Health Economic Modeling Initiatives within the MRL Biostatistics and Research Decision Sciences(BARDS) Epidemiology RWE Capabilities and Analytics working...

CloseMore

×

Christopher Bishop / When Quantum Meets Pharma: Inside the Race to Design Drugs Atom by Atom

Christopher Bishop, Chief Reinvention Officer,
Improvising Careers

Christopher Bishop is a TEDx speaker, ex-IBMer, former NYC studio cat, touring rock musician, future workplace consultant, and a firm believer in the power of bleeding-edge technologies to drive exciting and innovative careers. He is the author of the groundbreaking new book Improvising Careers:...

CloseMore

×

Brett Engelmann / Building Bridges: Developing a Common Omics Data Platform at AbbVie

Brett Engelmann, Sr Data Scientist,
AbbVie

Brett is an experienced scientific informatics leader with extensive bioinformatics, omics data-platform, and scientific web-application development experience within a top pharmaceutical company. He is a team player who is passionate about omic applications for target ID, mechanism of action, and...

CloseMore

×

Harish Manmathan / From Silos to FAIR: Driving Data Strategy in Research and Development

Harish Manmathan, Sr. Director, Trial Delivery Data Strategy,
Takeda

Global lead responsible for defining and enabling the end‑to‑end data strategy for clinical development at Takeda R&D. I focus on how clinical trial data is collected, stored, managed, reported, and utilized across the full development lifecycle to drive better, faster, and more reliable...

CloseMore

×

Venkat Sanka / Chair's remarks

Venkat Sanka, Data Analytics & Governance Consultant,
Janssen Global Services LLC

Venkat Sanka is a seasoned data and cloud analytics leader with over 16 years of experience enabling data-driven transformation across healthcare, life sciences, and global enterprises. He currently works in data analytics and governance, leading initiatives in AI/ML, cloud platforms, and trusted...

CloseMore

×

Angela Gill Nelms / Chair's remarks

Angela Gill Nelms, Managing Director,
Biolocity at GT and Emory

I’m a founder, board leader, podcaster, and award-winning entrepreneur with a career spanning SaaS, medical devices, and clinical research. I build high-impact teams and organizations rooted in culture, resilience, and strategic execution—globally and sustainably. I host three shows that each...

CloseMore

×

Sally Thompson-Iritani / How AI is used to support the three R’s in drug discovery

Sally Thompson-Iritani, Asst. Vice Provost, Animal Care, Outreach & 3Rs,
University of Washington

Sally Thompson-Iritani is an accomplished professional with a passion for advancing animal care, outreach, and the principles of the 3Rs (Replacement, Reduction, Refinement) in research. As the Assistant Vice Provost at the University of Washington, she leads initiatives to promote ethical and...

CloseMore

×

MaryLena Bleile / An ensemble method for robust labelling of single-cell RNA-seq data

MaryLena Bleile, Senior Statistician,
Sanofi

AI Research Scientist working at the intersection of causal inference and reinforcement learning. Currently writing a technical book on causal agents contracted to CRC Press (forthcoming 2027).Previously I led an interdisciplinary initiative in biopharma which saved up to $100k+ on clinical...

CloseMore